Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma

Show other versions (1)

Bibliographic Details
Main Authors:	Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco‐Aparicio, Cristian Garcia‐Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer vonStedingk, Daniel Bexell
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	EMBO Molecular Medicine
Online Access:	https://doi.org/10.15252/emmm.201911749

Similar Items

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
by: Sofie Mohlin, et al.
Published: (2019-08-01)

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
by: Gillian Moore, et al.
Published: (2021-04-01)

Anti-tumor effects of rigosertib in high-risk neuroblastoma
by: Katarzyna Radke, et al.
Published: (2021-08-01)

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
by: Sabina Luszczak, et al.
Published: (2020-09-01)

Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.
by: Michael K Kiessling, et al.
Published: (2016-01-01)

Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.
by: Michael K Kiessling, et al.
Published: (2017-01-01)

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
by: Matthew J. Kling, et al.
Published: (2021-09-01)

Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes
by: Arun Samidurai, et al.
Published: (2020-12-01)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
by: Aziz Ur Rehman Aziz, et al.
Published: (2018-02-01)

IBL in GUI for mobile devices
by: Nilsson, Andreas
Published: (2011)

Sequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.
by: Mike-Andrew Westhoff, et al.
Published: (2013-01-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
by: Tian Tian, et al.
Published: (2019-02-01)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
by: Kerstin Tiedemann, et al.
Published: (2017-05-01)

Spatially Varying IBL Using Light Probe Sequences
by: Khoury, Richard
Published: (2009)

A study on the postposition of adjectives ending in-ible and -able
by: Renman, Josefin
Published: (2021)

mTOR, autophagy and reprogramming
by: Bor Luen eTang
Published: (2014-01-01)

mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01)

mTOR in Human Diseases
by: Olivier Dormond
Published: (2019-05-01)

mTOR in Human Diseases
Published: (2019)

Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma
by: Paolo Uva, et al.
Published: (2021-06-01)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Tanjala T. Gipson, et al.
Published: (2012-01-01)

Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models
by: Sushil Kumar, et al.
Published: (2018-08-01)

Development of the readout for the IBL Upgrade Project of the ATLAS Pixel Detector
by: Krieger, Nina
Published: (2012)

Targeting mTOR for cancer therapy
by: Hui Hua, et al.
Published: (2019-07-01)

mTOR Signaling in Metabolism and Cancer
by: Shile Huang
Published: (2020-10-01)

Biological Aspects of mTOR in Leukemia
by: Simone Mirabilii, et al.
Published: (2018-08-01)

Role of mTOR Complexes in Neurogenesis
by: Francesca LiCausi, et al.
Published: (2018-05-01)

The paradox of Akt -mTOR interactions
by: LAKSHMIPATHI eVADLAKONDA, et al.
Published: (2013-06-01)

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

mTOR Signaling in Metabolism and Cancer
Published: (2020)

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
by: Amadesi, C., et al.
Published: (2022)

AZD1208, a Pan-Pim Kinase Inhibitor, Has Anti-Growth Effect on 93T449 Human Liposarcoma Cells via Control of the Expression and Phosphorylation of Pim-3, mTOR, 4EBP-1, S6, STAT-3 and AMPK
by: Anil Kumar Yadav, et al.
Published: (2019-01-01)

Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies
by: Jing-Wei Lyu, et al.
Published: (2019-04-01)

All PI3Kinase signaling is not mTOR: Dissecting mTOR-dependent and independent signaling pathways in T cells
by: Christopher Jordan Gamper, et al.
Published: (2012-10-01)

Pim-1 inhibitor SMI-4a suppresses tumor growth in non-small cell lung cancer via PI3K/AKT/mTOR pathway
by: Jiang W, et al.
Published: (2019-04-01)

Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells
by: Ji Hye Park, et al.
Published: (2020-04-01)

Development of pixel detectors for the IBL and HL-LHC ATLAS experiment upgrade
by: Baselga Bacardit, Marta
Published: (2016)

Integration of Inquiry-Based Learning (IBL) with Real World Problem-Solving
by: Suzanne K. Lunsford
Published: (2019-10-01)